Printer Friendly
The Free Library
14,538,038 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

RU 486: headed for the United States?


Late last month, Roussel Uclaf, a French pharmaceutical firm, agreed to give up U.S. patent rights to the abortion pill abortion pill See Contragestive, Oral contraceptive, RU-486.  known as RU 486 (mifepristone Mifepristone Definition

Mifepristone is a pill that can be taken as an alternative to a surgical abortion.
Purpose

This medication most often is used for ending early pregnancies.
). Roussel donated the drug's U.S. rights to the Population Council, a nonprofit contraceptive research group based in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
. The move is expected to pave the way for marketing the pill in the United States. RU 486 is widely available in France, Britain, Germany, and Sweden.

Roussel had been reluctant to bring RU 486 to the United States because of opposition by the antiabortion an·ti·a·bor·tion  
adj.
Opposed to induced abortion: the antiabortion movement.



an
 movement. The Clinton administration is credited with urging the French firm to work out an agreement with the Population Council.

Officials at the council say they will begin conducting clinical trials of RU 486, a step necessary to gaining Food and Drug Administration approval. The council is already searching for a drug company to manufacture and distribute the drug in the United States. Despite the controversial nature of the pill, the group has already received calls from interested pharmaceutical firms, says the Population Council's Sandra Waldman.

RU 486 works by blocking the action of progesterone progesterone (prōjĕs`tərōn'), female sex hormone that induces secretory changes in the lining of the uterus essential for successful implantation of a fertilized egg. , a hormone required to maintain pregnancy. Women must return to their doctor's office within 48 hours of taking the drug to get a dose of prostaglandin prostaglandin (prŏs'təglăn`dən), any of a group of about a dozen compounds synthesized from fatty acids in mammals as well as in lower animals. , which triggers the expulsion of the embryo or fetus.

The drug still faces formidable opposition. This week, a coalition of antiabortion groups launched a campaign to keep this drug from being marketed in the United States.
COPYRIGHT 1994 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Roussel Uclaf donates its US rights for the abortion pill to nonprofit contraceptive research group Population Council
Publication:Science News
Date:Jun 4, 1994
Words:249
Previous Article:Other cryptic creatures. (International Society of Cryptozoology gathers evidence of creatures that may or may not exist such as the Vietnamese sharp...
Next Article:Fatal breast cancer and smoking. (women who smoke face greater risk of dying from breast cancer than woman who do not smoke) (Brief Article)
Topics:



Related Articles
'Abortion pill': new data, new markets.
New use for the French 'abortion' pill. (RU 486 may be used as morning-after pill)
Selling RU-486.(Food and Drug Administration rushes approval of abortion drug)(Editorial)
WORTH NOTING.(Brief Article)
HARD PILL TO SWALLOW.(medical abortions)(Brief Article)
Weak choice: The abortion pill. (Citings).(Henry J. Kaiser Family Foundation survey on Mifepristone use)(Brief Article)(Statistical Data Included)
Women on Waves to distribute RU 486. (International).(Brief Article)
Abortion pill tragedy.(Insider Report)
RU-486 claims two more lives.(England)(Brief Article)
Availability of services for emergency contraceptive pills at high school--based health centers.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles